Jefferies Upgrades Medpace Hldgs to Buy, Raises Price Target to $450
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst David Windley upgraded Medpace Holdings (MEDP) from Hold to Buy and increased the price target from $340 to $450, indicating a positive outlook on the company's stock.

April 23, 2024 | 3:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies upgraded Medpace Holdings to Buy from Hold and raised the price target to $450, showing a bullish stance on the stock.
An upgrade from Hold to Buy typically signals an analyst's increased confidence in a company's future performance and growth prospects. The significant raise in price target from $340 to $450 by a reputable analyst firm like Jefferies can lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100